Clinical Trials Browser

Phase 2 × Myelodysplastic Syndromes × Sitagliptin Phosphate × Clear all

NCT01720264 2019-01-08

Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma